Patents Assigned to F2G Ltd.
  • Patent number: 11819503
    Abstract: The invention relates to the therapeutic use of olorofim, 2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-(4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)phenyl)-2-oxoacetamide in the prevention and treatment of a fungal infection caused by a Coccidioides species.
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: November 21, 2023
    Assignees: F2G Ltd
    Inventors: Derek Law, John H. Rex, Michael Birch, Nathan P. Wiederhold, Thomas F. Patterson
  • Patent number: 9487813
    Abstract: A method of identifying an antifungal agent which targets a PPTB protein of a fungus comprising determining whether a candidate compound binds to or inhibits a PPTB protein, wherein binding or inhibition indicates that the candidate substance is an antifungal agent.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: November 8, 2016
    Assignee: F2G LTD
    Inventors: Jason David Oliver, Katharine Sarah Dobb, Sarah Jane Kaye, John Leslie Thain, Daniel Scott Tuckwell, Michael John Bromley
  • Patent number: 9452168
    Abstract: The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: September 27, 2016
    Assignee: F2G LTD
    Inventors: Graham Edward Morris Sibley, Robert Downham, Lloyd James Payne, Derek Law, Jason David Oliver, Michael Birch, Gareth Morse Davies
  • Patent number: 8993574
    Abstract: The invention provides compounds of formula (I), and pharmaceutically and agriculturally acceptable salts thereof; wherein: R1, R2, R3, R4, R5, R6, A1, L1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
    Type: Grant
    Filed: April 23, 2009
    Date of Patent: March 31, 2015
    Assignee: F2G Ltd
    Inventors: Graham Edward Morris Sibley, Robert Downham, Lloyd James Payne, Derek Law, Jason David Oliver, Mike Birch, Gareth Morse Davies, Patricia Suling Davies
  • Patent number: 8604029
    Abstract: The invention provides compounds of formula (I), and pharmaceutically acceptable salts thereof wherein: R1, R2, R3, R4, R5, R6, R7, X and X1 are as defined herein. These compounds are useful in the manufacture of medicaments for use in the prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: December 10, 2013
    Assignee: F2G Ltd British Body Corporate
    Inventors: Robert Downham, Graham Edward Morris Sibley, Lloyd James Payne, Philip Edwards, Gareth Morse Davies
  • Patent number: 8486962
    Abstract: Compounds of formula (I), and pharmaceutically acceptable salts thereof, may be used in therapy, for example as antifungal agents: (I) wherein: R1, R2, R3, R4, R5, R6, R7, X and X1 are as defined herein. Certain compounds of formula (I) are also provided. Compounds of formula (T), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
    Type: Grant
    Filed: May 18, 2006
    Date of Patent: July 16, 2013
    Assignee: F2G Ltd.
    Inventors: Samantha Patricia Thomson, Rhian Teresa Davies, Nigel Mark Allanson, Alexandre Kuvshinov, Gareth Morse Davies, Philip Neil Edwards
  • Publication number: 20080206220
    Abstract: Method of identifying an anti-fungal agent which targets an essential protein or gene of a fungus comprising contacting a candidate substance with (i) a NADH:flavin oxidoreductase protein which comprises the sequence shown by SEQ ID NO:3, (ii) a NADH:flavin oxidoreductase protein which is a homologue of (i) and which comprises the sequence shown by SEQ ID NO: 8, 12, 14, 19, 24, 42, 44, 83 or 85, (iii) a protein which has 50% identity with (i) or (ii), (iv) a protein comprising a fragment of (i), (ii) or (iii) which fragment has a length of at least 50 amino acids, (v) a polynucleotide that comprises sequence which encodes (i), (ii), (iii) or (iv), (vi) a polynucleotide comprising sequence which has at least 70% identity with the coding sequence of (v), and determining whether the candidate substance binds or modulates (i), (ii), (iii), (iv), (v) or (vi), wherein binding or modulation of (i), (ii), (iii), (iv), (v) or (vi) indicates that the candidate substance is an anti-fungal agent.
    Type: Application
    Filed: February 18, 2005
    Publication date: August 28, 2008
    Applicant: F2G LTD
    Inventors: Sandra Elizabeth Lavens, Jason David Oliver, John Leslie Thain, Daniel Scott Tuckwell, Michael John Bromley
  • Publication number: 20080161302
    Abstract: Compounds of formula (I), and pharmaceutically acceptable salts thereof, may be used in therapy, for example as antifungal agents: (I) wherein: R1, R2, R3, R4, R5, R6, R7, X and X1 are as defined herein. Certain compounds of formula (I) are also provided. Compounds of formula (T), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
    Type: Application
    Filed: May 18, 2006
    Publication date: July 3, 2008
    Applicant: F2G Ltd.
    Inventors: Samantha Patricia Thomson, Rhian Teresa Davies, Nigel Mark Allanson, Alexandre Kuvshinov, Gareth Morse Davies, Philip Neil Edwards